In patients with established RA, a chemokine gradient with higher levels in synovial fluid compared to blood has been reported for CXCL10, CXCL9, CCL2, CCL3, CCL4, and CXCL8 [38]. This evidence concerns the gene CCL2 and rheumatoid arthritis.